NCT05369689View on ClinicalTrials.gov

Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

June 1, 2027

Conditions
Stereotactic RadiosurgerySpinal TumorRadiomicsPrognosis
Interventions
OTHER

No interventions

As this is a prognosis evaluation study, there are no interventions.

Trial Locations (1)

100191

Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist., Beijing

All Listed Sponsors
lead

Zhuang Hongqing

OTHER

NCT05369689 - Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics | Biotech Hunter | Biotech Hunter